Frontlight ResearchEarly access
Haemophilia trials in France
15 of 26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Bron, Paris
- Age
- 18 years and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - Phase 4Taking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Nantes, Tours
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - Phase 4Taking peopleNuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Chambray-lès-Tours, Nantes, Strasbourg
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Bron, Le Kremlin Bicetre Cedex, Lille, Paris
- Age
- 12 years and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - Phase 3Not yet taking people in FranceA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Bron, Le Kremlin-Bicetre, Lille, Nantes
- Age
- 18 years and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - Phase 3Taking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Paris
- Age
- 1 year to 74 years
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Bron, Le Kremlin Bicetre Cedex, Lille
- Age
- 12 years and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - Phase 3Taking peopleA Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
- Where
- Bron, Paris
- Age
- 18 years to 64 years
- People
- 32 worldwide
- Run by
- Pfizer Inc.
See details and how to join2025-523660-21-00 - Phase 1/2Taking peopleA Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Where
- Bron, Lille, Paris
- Age
- 2 years and over
- People
- 130 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06379789 · EU 2023-507260-40-00 - Phase 3Taking peoplePhase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Where
- Lille, Marseille
- Age
- 138 months to 206 months
- People
- 20 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00 - Phase 3CompletedA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Paris
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - Phase 1CompletedA Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Bron
- Age
- 18 years to 64 years
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00 - No phaseNot yet taking people in FranceUltrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)
- Where
- Paris
- Age
- 18 years and over
- People
- 150
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07719647 - Phase 4Taking peopleNuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Nantes, Strasbourg Cedex 2, Tours
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00 - Phase 4Taking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Nantes, Tours
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00